Arthritis, Experimental/drug therapy; Insulin-Like Growth Factor Binding Protein 3/metabolism; Insulin-Like Growth Factor I/administration & dosage; Muscle Proteins/metabolism; Muscle, Skeletal/drug effects; Muscular Atrophy/prevention & control; SKP Cullin F-Box Protein Ligases/metabolism; Animals; Arthritis, Experimental/metabolism; Arthritis, Experimental/microbiology; Arthritis, Experimental/pathology; Body Weight; Chronic Disease; Disease Models, Animal; Down-Regulation; Glycolysis; Humans; Injections, Subcutaneous; Insulin-Like Growth Factor Binding Protein 5/metabolism; Male; Muscle Fibers, Fast-Twitch/drug effects; Muscle Fibers, Fast-Twitch/metabolism; Muscle Fibers, Slow-Twitch/drug effects; Muscle Fibers, Slow-Twitch/metabolism; Muscle, Skeletal/metabolism; Muscle, Skeletal/pathology; Muscular Atrophy/metabolism; Muscular Atrophy/microbiology; Muscular Atrophy/pathology; Mycobacterium; MyoD Protein/metabolism; Organ Size; Oxidation-Reduction; Proliferating Cell Nuclear Antigen/metabolism; Rats; Rats, Wistar; Recombinant Proteins/administration & dosage; Severity of Illness Index; Time Factors; Tripartite Motif Proteins; Ubiquitin-Protein Ligases/metabolism